PPAR inhibitor, Rosiglitazone maleate, Purity ≥98%

Synonym: 155141-29-0; Avandia; Avandamet; Avandaryl; (Z)-But-2-enedioic acid; 5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione

MDL: MFCD03427306
CAS Number: 155141-29-0
Compound CID: 5281055

Product Size

25 mg; 50 mg; 100 mg; 200 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Rosiglitazone maleate, soluble in DMSO and insoluble in water and ethanol, is an effective cell metabolism inhibitor, that has the ability to prevent the pathway of metabolism by inhibiting PPAR. It targets the PPARγ.

Molecular Weight

473.5

Molecular Formula

C₂₂H₂₃N₃O₇S

Targets

PPARγ: 42 nM

Form

Lyophilized powder

Purity

≥98%

Titer

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects

Solubility

In vitro: DMSO: 89 mg/mL (187.96 mM); Water: insoluble; Ethanol: insoluble

Applications

Rosiglitazone maleate is a metabolism inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of type 2 diabetes by enhancing insulin sensitivity.